corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 121 of 144 pages ‹ First  < 119 120 121 122 123 >  Last ›

HSL15
Dougherty K .
Ottawa needs to rein in ads by drug firms: Nobody is complaining about them, Alliance says
The Gazette 2003 Oct 29

HSL1464
Biswas S.
Indian drugs boss hails Aids deal
BBC News 2003 Oct 29
http://news.bbc.co.uk/2/hi/americas/3220619.stm

HSL1462
Harris G.
F.D.A. Intensely Reviews Depression Drugs
The New York Times 2003 Oct 28

HSL1463
Foster J.
FDA advisory urges caution in children's use of antidepressants
The Herald 2003 Oct 28

HSL1444
FDA Issues Public Health Advisory Entitled: Reports Of Suicidality in Pediatric Patients Being Treated with Antidepressant Medications for Major Depressive Disorder (MDD)
2003 Oct 27

HSL1461
Kaufman M.
FDA Cautions on Antidepressants and Youth
The Washington Post 2003 Oct 27

HSL17
Davis D .
Losing the Mind: David Oaks and Others in the 'Mad Pride' Movement Believe Drugs Are Being Overused in Treating Mental Illness, and They Want the Abuse to Stop.
Los Angeles Times 2003 Oct 26
http://pqasb.pqarchiver.com/latimes/access/430966241.html?dids=430966241:430966241&FMT=ABS&FMTS=ABS:FT&type=current&date=Oct+26%2C+2003&author=David+Davis&pub=Los+Angeles+Times&edition=&startpage=I.20&desc=Losing+the+Mind

HSL1443
Kluger J.
Medicating Young Minds: Drugs have become increasingly popular for treating kids with mood and behavior problems. But how will that affect them in the long run?
The Times Online 2003 Oct 26

HSL1442
Vedantam S.
AIDS Plan Would Cut Drug Costs for Poor: WHO Would Provide 3-in-1 Pill to Nations
The Washington Post 2003 Oct 25
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&node=&contentId=A14310-2003Oct24¬Found=true

HSL9953
The statin wars: why AstraZeneca must retreat.
Lancet. 2003 Oct 25; 362:(9393):1341
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/S0140-6736(03)14669-7

HSL18067
Dyer O.
Drug company and pharmacy send unsolicited samples of Prozac to Florida residents.
BMJ 2003 Oct 25; 327:(7421):950
http://www.bmj.com/cgi/content/full/327/7421/950-a?view=long&pmid=14576244

HSL18072
Sidley P.
Competition body rules that drug companies
BMJ 2003 Oct 25; 327:(7421):946
http://www.bmj.com/cgi/content/full/327/7421/946-a?view=long&pmid=14576226

HSL18069
Sibbald B
Rules that extend drug patents face challenge
CMAJ 2003 Oct 23; 169:(9):950
http://www.cmaj.ca/cgi/content/full/169/9/950-a

HSL18
Parker-pope , T .
The Case for Hormone Therapy: Menopause hormones have been battered by recent studies highlighting their potential dangers. Here's why women might still want to take them.
The Wall Street Journal 2003 Oct 21

HSL2149
Dowden JS.
Coax, COX and cola: Manufacturers’ claims in well funded marketing campaigns cannot replace the test of time
Med J Aust 2003 Oct 20; 179:(8):397-8
http://www.mja.com.au/public/issues/179_08_201003/dow10457_fm-2.html

HSL367
Sweet M.
Website launched to expose "tricks" of drug ads
BMJ 2003 Oct 18; 327:(7420):936
http://bmj.bmjjournals.com/cgi/content/full/327/7420/936

HSL18068
Moynihan R.
Cochrane at crossroads over drug company sponsorship.
BMJ 2003 Oct 18; 327:(7420):924-6
http://www.bmj.com/cgi/content/full/327/7420/924?view=long&pmid=14563759

HSL5476
Mansfield PR.
Drug company sponsorship would endanger health care improvement
BMJ 2003 Oct 17; 327:
http://bmj.bmjjournals.com/cgi/eletters/327/7420/924

HSL19
Drug incentive schemes under fire: Pharmaceutical firms accused of overstepping advertising rules
NetDoctor.co.uk 2003 Oct 15

HSL18074
Sibbald B.
Canadian media say DTC pharma ads the right Rx.
CMAJ 2003 Oct 14; 169:(8):822
http://www.cmaj.ca/cgi/content/full/169/8/822-a

HSL1440
Hensley S.
Court Revives Suit Against Pfizer On Nigeria Study
The Wall Street Journal 2003 Oct 13

HSL1441
Klein N.
Bush's Aids 'gift' has been seized by industry giants: Now the US may block the provision of cheap generic drugs for Africa
The Guardian 2003 Oct 13
http://www.guardian.co.uk/world/2003/oct/13/wto.aids

HSL3807
Brett AS, Burr W, Moloo J.
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians
Archives of Internal Medicine 2003 Oct 13; 163:(18):2213-2218
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14557219

HSL10237
Weeks RL.
Separation of anxiety and depressive disorders: normal rules of critical evaluation were presumably suspended.
BMJ 2003 Oct 11; 327:(7419):869
http://www.bmj.com/cgi/content/full/327/7419/869-a

HSL18070
Hopkins Tanne J
FDA chief wants other rich countries to share drug development costs
BMJ 2003 Oct 11; 327:(7419):830
http://www.bmj.com/cgi/content/extract/327/7419/830-d

HSL18071
Bonaccorso S, Sturchio JL
What information do patients need about medicines? Perspectives from the pharmaceutical industry.
BMJ 2003 Oct 11; 327:(7419):863
http://www.bmj.com/cgi/content/full/327/7419/863?view=long&pmid=14551109

HSL1439
The Community News Department at CKUT Radio McGill announces... "Pharmed and Dangerous: the Pharmaceutical Industry in Canada"
2003 Oct 10

HSL4477
Saunders C.
New web site targets drug ads.
Australian Doctor Weekly 2003 Oct 10

HSL1437
Andrews E.
Senate Panel Backs Bill to Give Tax Windfall to U.S. Companies
The New York Times 2003 Oct 2
http://www.nytimes.com/2003/10/02/business/02TAX.html

HSL1438
Dobbs L.
Over-medication: a growing crisis Aggressive marketing a major culprit
Tribune Media Services 2003 Oct 2

HSL1435
Nilson asks Ottawa to reject pharmaceutical ads
CBC Saskatchewan 2003 Oct 1

HSL1436
Boseley S.
Scientist in rethink over drug link to suicide
The Guardian 2003 Oct 1

HSL10241
Bross PF, Baird A, Chen G, Jee JM, Lostritto RT, Morse DE, Rosario LA, Williams GM, Yang P, Rahman A, Williams G, Pazdur R.
Fulvestrant in postmenopausal women with advanced breast cancer.
Clin Cancer Res 2003 Oct 1; 9:(12):4309-17
http://clincancerres.aacrjournals.org/cgi/content/full/9/12/4309

HSL422
Mansfield PR.
Healthy scepticism.
Aust Fam Physician 2003 Oct; 32:(10):777

HSL1238
Booth B, Zemmel R.
Quest for the best.
Nat Rev Drug Discov 2003 Oct; 2:(10):838-41
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrd/journal/v2/n10/abs/nrd1203_fs.html&dynoptions=doi1114941377

HSL1906
Peebles ME.
And now, a word from our sponsor.
Harv Bus Rev 2003 Oct; 81:(10):31-5

HSL2329
Mizik M, Jacobsen R
Are Physicians Easy Marks?: Quantifying the effects of Detailing and Sampling on New Prescriptions.
Unpublished 2003 Oct;

HSL2333
Prosser H, Walley T.
New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
Fam Pract 2003 Oct; 20:(5):583-91
http://fampra.oxfordjournals.org/cgi/content/full/20/5/583

HSL9940
Finucane AK.
From the Epilepsy Foundation: restoring the Pediatric Rule.
Epilepsy Behav 2003 Oct; 4:(5):453-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WDT-4979HJH-3&_user=10&_coverDate=10%2F31%2F2003&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=037a849c55b3c7b3773bce79f4cc3873

HSL9951
Wang YR, Pauly MV, Lin YA.
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary.
Am J Manag Care 2003 Oct; 9:(10):686-96
http://www.ncbi.nlm.nih.gov/pubmed/14572179

HSL9952
Grabowski H.
The ripple effects of a restrictive Medicaid formulary.
Am J Manag Care 2003 Oct; 9:(10):648-9
http://www.ajmc.com/Article.cfm?ID=2470&CFID=8980495&CFTOKEN=81996035

HSL10244
Martin A, Leslie D.
Trends in psychotropic medication costs for children and adolescents, 1997-2000.
Arch Pediatr Adolesc Med 2003 Oct; 157:(10):997-1004
http://archpedi.ama-assn.org/cgi/content/full/157/10/997

HSL10245
Dominick KL, Dudley TK, Grambow SC, Oddone EZ, Bosworth HB.
Racial differences in health care utilization among patients with osteoarthritis.
J Rheumatol 2003 Oct; 30:(10):2201-6

HSL10248
Spina E, Scordo MG, D'Arrigo C.
Metabolic drug interactions with new psychotropic agents.
Fundam Clin Pharmacol 2003 Oct; 17:(5):517-38
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1472-8206.2003.00193.x

HSL10249
Barnes Recker CK, Hoehns JD, Sutherland JE, Opheim EF.
An online misadventure with haloperidol.
Ann Pharmacother 2003 Oct; 37:(10):1531

HSL1433
Disclosure at the Medical Journals
NY Times, Editorial 2003 Sep 30

HSL18084
OxyContin class-action suit to proceed
CMAJ 2003 Sep 30; 169:(7):
http://www.cmaj.ca/cgi/content/full/169/7/699-b

HSL16
Researchers Call On Federal Government to Create Breast Implant Registry Health Complications from Breast Implant Surgery Common
From the British Columbia Centre of Excellence for Women's Health and the Canadian Women's Health Network 2003 Sep 29

HSL1432
Rowland C.
Springfield mayor urges fiscal strike at drug companies
The Boston Globe 2003 Sep 29
http://www.boston.com/news/nation/articles/2003/09/29/springfield_mayor_urges_fiscal_strike_at_drug_companies_boston_globe/

HSL57
Bowe C .
US drug regulator slams European pricing
The Financial Times 2003 Sep 27

HSL284
Mansfield PR, Mintzes B.
Direct-to-consumer advertising is more profitable if it is misleading.
N Z Med J 2003 Sep 26; 116:(1182):U610
http://www.nzma.org.nz/journal/116-1182/610/

HSL1430
Leingang M.
Sexologist: Drug firms dupe women
Democrat and Chronicle 2003 Sep 25

HSL1431
Mathews A.
FDA Chief Targets Europe's Controls On Drug Prices
The Wall Street Journal 2003 Sep 25

HSL19047
Woloshin S, Schwartz LM, Ellner A.
Making sense of risk information on the web.
BMJ 2003 Sep 25; 327:(7417):695-6
http://www.bmj.com/content/327/7417/695.long

HSL17972
Ives N
FDA Reviews Ads for Drugs
The New York Times 2003 Sep 23

HSL62
Kaufman , M .
Drug Ads Do More Good Than Harm, FDA Told Agency Reviewing Effects, Perceptions of Direct-to-Consumer Advertising
The Washington Post 2003 Sep 23

HSL64
Smith, L .
The DES Legacy
The Washington Post 2003 Sep 23

HSL1427
Capps L.
Stark introduces fair balance prescription drug advertisement Act: Bill would ensure fair and accurate prescription drug advertising
2003 Sep 23
http://www.house.gov/stark/news/news_09-23-03_DTC.htm

HSL1428
Peterson M.
A Conversation With Sheldon Krimsky: Uncoupling Campus and Company
The New York Times 2003 Sep 23
http://www.nytimes.com/2003/09/23/science/a-conversation-with-sheldon-krimsky-uncoupling-campus-and-company.html?partner=rssnyt&emc=rss

HSL1429
Hallam K.
U.S. Deficit Cuts Republican Support for Bush's Medicare Plan
Bloomberg News 2003 Sep 23

HSL66
National Women's Health Network
FDA Approves New Version of the Pill
2003 Sep 22
http://www.womenshealthnetwork.org.

HSL1426
Calabro S.
Pfizer quietly begins effort to tout the positives of DTC
PR Week 2003 Sep 22

HSL69
Fiedler T.
Minnetonka company's patient-recruitment redefines doctors' role
Star Tribune 2003 Sep 21

HSL17971
McIlroy A
Nervousness, Panic And Shyness Are Now Part Of The Most-Diagnosed Group Of Mental Illnesses - And Drug Companies Just Happen To Have An Array Of Products To Treat Them. Is Marketing The Tail Wagging This Dog?
The Globe and Mail 2003 Sep 20

HSL1425
Wright O.
Crackdown on antidepressants given out 'like sweets'
The Times Online 2003 Sep 20
http://www.timesonline.co.uk/tol/news/uk/article996942.ece

HSL18076
Smith R
A bad week for drug companies?
BMJ 2003 Sep 20; 327:(7416):
http://www.bmj.com/cgi/content/full/327/7416/0-g

HSL18077
Kmietowicz Z
NICE is told to break its close links with drug industry
BMJ 2003 Sep 20; 327:(7416):637
http://www.bmj.com/cgi/content/full/327/7416/637

HSL18078
Eaton L.
Drug companies must do more for poor countries, conference is told.
BMJ 2003 Sep 20; 327:(7416):642
http://www.bmj.com/cgi/content/full/327/7416/642-c?view=long&pmid=14500432

HSL18079
Moynihan R.
US politicians want federal funding to discover cost effectiveness of new drugs.
BMJ 2003 Sep 20; 327:(7416):642
http://www.bmj.com/cgi/content/full/327/7416/642?view=long&pmid=14500428

HSL72
118 Essential medicines missing on the market: survey
Daily Dawn 2003 Sep 18

HSL9935
DeAngelis CD, Fontanarosa PB.
Drugs alias dietary supplements.
JAMA 2003 Sep 17; 290:(11):1519-20
http://jama.ama-assn.org/cgi/content/full/290/11/1519

HSL73
Morrice D .
Drug advertising is bad medicine A needed prescription
Toronto Star 2003 Sep 16

HSL18083
Cassels A.
World's first nonprofit drug company launched.
CMAJ 2003 Sep 16; 169:(6):590
http://www.cmaj.ca/cgi/content/full/169/6/590

HSL75
Industry discourages study of new drugs' effectiveness
USA Today 2003 Sep 14

HSL18080
Spurgeon D.
'Direct to consumer' advertising of drugs in Canada could add £550m to healthcare costs.
BMJ 2003 Sep 13; 327:(7415):582
http://www.bmj.com/cgi/pmidlookup?view=long&pmid=12969919

HSL77
U.S. Sues Company for Importing Drugs from Canada
Reuters 2003 Sep 11

HSL1422
Kanter J.
EU Court's Top Adviser Backs Drug Discounters
The Wall Street Journal 2003 Sep 11

HSL79
Wolfe SM.
Food and Drug Disaster
The Washington Post 2003 Sep 10

HSL17970
Ruttan S
Sugar-coated pills
The Edmonton Journal 2003 Sep 7

HSL4478
Mansfield PR.
What mum said.
Australian Doctor Weekly 2003 Sep 4

HSL1421
Laucius J.
Consumer drug ads 'will hurt medicare'
Ottawa Citizen 2003 Sep 2

HSL1913
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA.
How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA
CMAJ. 2003 Sep 2; 169:(5):405-12
http://www.cmaj.ca/cgi/content/full/169/5/405

HSL3693
Gardner DM, Mintzes B, Ostry A.
Direct-to-consumer prescription drug advertising in Canada: permission by default?
CMAJ 2003 Sep 2; 169:(5):425-7
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=12952804&db=pubmed&url=http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=12952804

HSL18081
Ed.
Ads and prescription pads.
CMAJ 2003 Sep 2; 169:(5):381,
http://www.cmaj.ca/cgi/content/full/169/5/381

HSL18082
Chepesiuk R.
Supported by an unrestricted educational grant.
CMAJ 2003 Sep 2; 169:(5):421-2
http://www.cmaj.ca/cgi/content/full/169/5/421

HSL4780
Ben Abdelaziz A, Harrabi I, Rahmani S, Ghedira A, Gaha K, Ghannem H.
[Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
East Mediterr Health J. 2003 Sep-Nov;9(5-6):1075-83. 2003 Sep-Nov 01; 9:(5-6):1075-83

HSL5332
Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R.
Reduction in antibiotic use among US children, 1996-2000.
Pediatrics 2003 Sep 01; 112:(3):
http://pediatrics.aappublications.org/cgi/content/full/112/3/620

HSL1179
Vaithianathan R.
Supply-side cost sharing when patients and doctors collude.
J Health Econ 2003 Sep; 22:(5):763-80

HSL1183
Richards D.
The problems and perils of prescription medicines.
Clin Med 2003 Sep-Oct; 3:(5):476-8

HSL1185
Mechanic D.
Is the prevalence of mental disorders a good measure of the need for services?
Health Aff (Millwood) 2003 Sep-Oct; 22:(5):8-20
http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=14515877

HSL1186
Mastroianni Pde C, Galduroz JC, Carlini EA.
Influence of the legislation on the advertisement of psychoactive medications in Brazil.
Rev Bras Psiquiatr 2003 Sep; 25:(3):146-55

HSL1207
Harris G, Mayho G, Page L.
Occupational health issues affecting the pharmaceutical sales force.
Occup Med (Lond) 2003 Sep; 53:(6):378-83
http://occmed.oupjournals.org/cgi/reprint/53/6/378

HSL1228
Coleman B.
Producing an information leaflet to help patients access high quality drug information on the Internet: a local study.
Health Info Libr J 2003 Sep; 20:(3):160-71
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1471-1834&date=2003&volume=20&issue=3&spage=160

HSL1903
Richards D.
Problems and perils of prescription medicines.
Expert Opin Drug Saf 2003 Sep; 2:(5):509-11
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3204&uid=12946251&db=pubmed&url=http://www.ashley-pub.com/doi/abs/10.1517/14740338.2.5.509

HSL3806
Hartmann M, Knoth H, Schulz D, Knoth S, Meier-Hellmann A.
Industry-sponsored economic studies in critical and intensive care versus studies sponsored by nonprofit organizations.
J Intensive Care Med 2003 Sep-Oct; 18:(5):265-8
http://jic.sagepub.com/cgi/reprint/18/5/265

HSL9954
An eye on the markets
Current Drug Discovery 2003 Sep; 43-44

HSL10259
Katz A.
Learning the lessons of the HRT fiasco.
Can Fam Physician 2003 Sep; 49:1078:

HSL10266
Sansgiry SS, Shringarpure GS.
Springtime confusion: are consumers getting the right information on how to treat seasonal allergies?
J Allergy Clin Immunol 2003 Sep; 112:(3):627-8
http://ezproxy.library.uq.edu.au/login?url=http://dx.doi.org/10.1016/S0091-6749(03)01618-X

HSL10279
Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH.
Infliximab treatment of rheumatoid arthritis and Crohn's disease.
Ann Pharmacother 2003 Sep; 37:(9):1256-65

HSL10355
Rosenheck R, Leslie D.
Administrative prescription review procedures and use of atypical antipsychotic medications in the Department of Veterans Affairs.
Ment Health Serv Res 2003 Sep; 5:(3):149-53
http://www.springerlink.com/content/jg5478m41775q581/

Page 121 of 144 pages ‹ First  < 119 120 121 122 123 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963